These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15256871)

  • 41. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of bioelectrical impedance analysis to assess liver steatosis.
    Bhati CS; Silva MA; Wigmore SJ; Bramhall SR; Mayer DA; Buckels JA; Neil DA; Murphy N; Mirza DF
    Transplant Proc; 2009 Jun; 41(5):1677-81. PubMed ID: 19545706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
    Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression.
    Ikura Y; Ohsawa M; Suekane T; Fukushima H; Itabe H; Jomura H; Nishiguchi S; Inoue T; Naruko T; Ehara S; Kawada N; Arakawa T; Ueda M
    Hepatology; 2006 Mar; 43(3):506-14. PubMed ID: 16496325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel cannulation technique for isolation of human hepatocytes from explanted diseased whole livers.
    Kehr DC; Raschzok N; Sauer IM
    Transplant Proc; 2012 May; 44(4):999-1001. PubMed ID: 22564608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
    Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
    Transpl Int; 2006 Oct; 19(10):807-13. PubMed ID: 16961772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
    Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model.
    Luo XY; Takahara T; Hou J; Kawai K; Sugiyama T; Tsukada K; Takemoto M; Takeuchi M; Zhong L; Li XK
    Biochem Biophys Res Commun; 2012 Jan; 417(1):287-93. PubMed ID: 22155236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of human hepatocytes isolated from non-transplantable livers.
    Łaba A; Ostrowska A; Patrzałek D; Paradowski L; Lange A
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):442-53. PubMed ID: 16314828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.
    Aurich I; Mueller LP; Aurich H; Luetzkendorf J; Tisljar K; Dollinger MM; Schormann W; Walldorf J; Hengstler JG; Fleig WE; Christ B
    Gut; 2007 Mar; 56(3):405-15. PubMed ID: 16928726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expansion of hepatic progenitor cell in fatty liver graft after living donor liver transplantation.
    Cho JY; Suh KS; Shin WY; Lee HW; Yi NJ; Kim MA; Jang JJ; Lee KU
    Transpl Int; 2010 May; 23(5):530-7. PubMed ID: 20003044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring donor demographics effects on hepatocyte yield and viability: Results of whole human liver isolation from one center.
    Geerts S; Ozer S; Chu C; Fuchs BC; Tanabe KK; Yeh H; Uygun K
    Technology (Singap World Sci); 2019; 7(1-2):1-11. PubMed ID: 31414037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of cultured human hepatocytes isolated from surgical biopsies or cold-stored organ donor livers.
    Vons C; Pegorier JP; Ivanov MA; Girard J; Melcion C; Cordier A; Franco D
    Toxicol In Vitro; 1990; 4(4-5):432-4. PubMed ID: 20702208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional Assessment of Cardiac Arrest Hepatocytes and Effect of Mechanical Perfusion on Function in a Rat Model.
    Takido N; Fujio A; Nishimaki H; Yamana H; Imura T; Kashiwadate T; Goto M; Unno M; Kamei T
    Transplant Proc; 2023 May; 55(4):1012-1015. PubMed ID: 37100736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Preoperative Chemotherapy on the Isolation Outcome of Primary Human Hepatocytes.
    Rissel M; Pohl J; Moosburner S; Gaßner JMGV; Horner R; Hillebrandt KH; Modest DP; Pratschke J; Sauer IM; Raschzok N
    Tissue Eng Part C Methods; 2023 Feb; 29(2):63-71. PubMed ID: 36694452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience.
    Bhogal RH; Hodson J; Bartlett DC; Weston CJ; Curbishley SM; Haughton E; Williams KT; Reynolds GM; Newsome PN; Adams DH; Afford SC
    PLoS One; 2011 Mar; 6(3):e18222. PubMed ID: 21479238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of human hepatocytes isolated from livers accepted or discarded for orthotopic transplantation.
    Groothuis GM; Sandker GW; Pruim J; Weert B; Slooff MJ; Meijer DK
    Toxicol In Vitro; 1995 Dec; 9(6):951-8. PubMed ID: 20650173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.